S E Purdon

Summary

Affiliation: Phoenix Program
Country: Canada

Publications

  1. ncbi request reprint Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia
    S E Purdon
    The University of Alberta and The Alberta Hospital Edmonton, Canada
    J Int Neuropsychol Soc 7:606-14. 2001
  2. ncbi request reprint Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia
    S E Purdon
    University of Alberta and Alberta Hospital, Edmonton, Canada
    Arch Gen Psychiatry 57:249-58. 2000
  3. ncbi request reprint Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
    S E Purdon
    Alberta Hospital Edmonton, Box 307, Edmonton, T5J 2J7, Alberta, Canada
    Schizophr Res 44:221-32. 2000
  4. ncbi request reprint Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol
    Scot E Purdon
    Department of Psychiatry, University of Alberta, CHA ANE, Box 307, Edmonton, Alberta, Canada T5J 2J7
    Psychopharmacology (Berl) 169:390-7. 2003
  5. pmc Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
    S E Purdon
    University of Alberta, Edmonton, Alta
    J Psychiatry Neurosci 26:137-49. 2001
  6. ncbi request reprint Menstrual effects on asymmetrical olfactory acuity
    S E Purdon
    Department of Psychiatry, University of Alberta, Edmonton, Canada
    J Int Neuropsychol Soc 7:703-9. 2001
  7. ncbi request reprint Cognitive improvement in schizophrenia with novel antipsychotic medications
    S E Purdon
    Neuropsychology, Alberta Hospital Edmonton, Alb, Canada
    Schizophr Res 35:S51-60. 1999
  8. ncbi request reprint Neuropsychological change in schizophrenia after 6 weeks of clozapine
    S E Purdon
    Department of Psychiatry, University of Alberta, Alberta, Edmonton, Canada
    Schizophr Res 48:57-67. 2001
  9. ncbi request reprint An fMRI investigation of procedural learning in unaffected siblings of individuals with schizophrenia
    Neil D Woodward
    Department of Psychology, Vanderbilt University, Nashville, TN 37203, USA
    Schizophr Res 94:306-16. 2007
  10. ncbi request reprint A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects
    Neil D Woodward
    Department of Psychology, Vanderbilt University, 301 Wilson Hall, 111 21st Ave S, Nashville, TN 37203, USA
    Schizophr Res 89:211-24. 2007

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia
    S E Purdon
    The University of Alberta and The Alberta Hospital Edmonton, Canada
    J Int Neuropsychol Soc 7:606-14. 2001
    ....
  2. ncbi request reprint Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia
    S E Purdon
    University of Alberta and Alberta Hospital, Edmonton, Canada
    Arch Gen Psychiatry 57:249-58. 2000
    ..The purpose of this investigation was to test the efficacy of novel antipsychotic medications in the treatment of cognitive impairment in early phase schizophrenia...
  3. ncbi request reprint Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
    S E Purdon
    Alberta Hospital Edmonton, Box 307, Edmonton, T5J 2J7, Alberta, Canada
    Schizophr Res 44:221-32. 2000
    ..Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment...
  4. ncbi request reprint Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol
    Scot E Purdon
    Department of Psychiatry, University of Alberta, CHA ANE, Box 307, Edmonton, Alberta, Canada T5J 2J7
    Psychopharmacology (Berl) 169:390-7. 2003
    ..Olanzapine is pharmacologically similar to clozapine and has a low incidence of EPS induction...
  5. pmc Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
    S E Purdon
    University of Alberta, Edmonton, Alta
    J Psychiatry Neurosci 26:137-49. 2001
    ..To assess the efficacy of quetiapine, a recently introduced second generation antipsychotic medication, in reducing cognitive impairment in patients with schizophrenia...
  6. ncbi request reprint Menstrual effects on asymmetrical olfactory acuity
    S E Purdon
    Department of Psychiatry, University of Alberta, Edmonton, Canada
    J Int Neuropsychol Soc 7:703-9. 2001
    ....
  7. ncbi request reprint Cognitive improvement in schizophrenia with novel antipsychotic medications
    S E Purdon
    Neuropsychology, Alberta Hospital Edmonton, Alb, Canada
    Schizophr Res 35:S51-60. 1999
    ....
  8. ncbi request reprint Neuropsychological change in schizophrenia after 6 weeks of clozapine
    S E Purdon
    Department of Psychiatry, University of Alberta, Alberta, Edmonton, Canada
    Schizophr Res 48:57-67. 2001
    ....
  9. ncbi request reprint An fMRI investigation of procedural learning in unaffected siblings of individuals with schizophrenia
    Neil D Woodward
    Department of Psychology, Vanderbilt University, Nashville, TN 37203, USA
    Schizophr Res 94:306-16. 2007
    ..Identification of genes related to the function of cerebral regions such as the prefrontal cortex, parietal lobe, and basal ganglia may assist in delineating the genetic contributions to schizophrenia...
  10. ncbi request reprint A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects
    Neil D Woodward
    Department of Psychology, Vanderbilt University, 301 Wilson Hall, 111 21st Ave S, Nashville, TN 37203, USA
    Schizophr Res 89:211-24. 2007
    ....
  11. ncbi request reprint One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia
    Richard S E Keefe
    Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27710, USA
    Schizophr Res 81:1-15. 2006
    ..Haloperidol-treated patients improved only on domains of learning/memory. However, patients able to remain in treatment for the entire 52 weeks benefited more from olanzapine or risperidone treatment than haloperidol treatment...
  12. ncbi request reprint A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
    Neil D Woodward
    Department of Psychology, Vanderbilt University, Nashville, TN 37203, USA
    Int J Neuropsychopharmacol 8:457-72. 2005
    ..Atypical antipsychotics produce a mild remediation of cognitive deficits in schizophrenia, and specific atypicals have differential effects within certain cognitive domains...
  13. ncbi request reprint Procedural learning in schizophrenia investigated with functional magnetic resonance imaging
    Lenka Zedkova
    Department of Psychiatry and Bebensee Schizophrenia Research Unit, University of Alberta, Edmonton, Alberta, Canada
    Schizophr Res 88:198-207. 2006
    ..The results are thus consistent with a neurodevelopmental pathology impinging on fronto-subcortical circuitry...
  14. ncbi request reprint [A brief scale to assess cognitive impairment in psychiatric patients]
    Oscar Pino
    Hospital Universitario de Bellvitge
    Psicothema 18:447-52. 2006
    ..There is also a language effect that may be due to sample and/or cultural characteristics. Finally, in both versions intra-class correlation coefficients and factorial structure are very similar...
  15. ncbi request reprint Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia
    Oscar Pino
    Department of Psychiatry, Hospital General Granollers Benito Menni CASM, Granollers, Barcelona, Spain
    Schizophr Res 99:139-48. 2008
    ..This study examined the psychometric properties of the Spanish version of the SCIP in a sample of outpatients suffering schizophrenia-spectrum disorders...
  16. doi request reprint Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia
    Scot E Purdon
    Bebensee Schizophrenia Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada
    Schizophr Res 99:218-24. 2008
    ..Elevated glutamate may relate to poor sustained attention and elevated risk of schizophrenia, suggesting a potential role for glutamate in an endophenotype for schizophrenia...